One of the UK's leading pharma companies has expressed its support for the Department of Health's five year Antimicrobial Resistance Strategy which was launched 13 September 2013
Europe is leading the way when it comes to transparency in clinical trials data. That's the view of regulatory lawyer Vincenzo Salvatore, senior counsel at Sidl 12 September 2013
As patent expiration becomes an increasing hurdle for pharma companies worldwide, The Pharma Letter spoke to patent attorney Gareth Williams, a partner at Marks 18 July 2013
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.